The company will now complete final commercial activities in preparation for targeting the 2.5 million peripheral vascular ...

Microbot Medical has received the FDA’s blessing for its miniature, remote-controlled robot for endovascular procedures, ...

Clearance makes Liberty the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular ...

With its remote endovascular procedure system currently under review at the FDA, Microbot Medical has put forward positive results from a pivotal study touting a 100% satisfaction rate among ...

Baptist Hospital of Miami is the second site to perform clinical procedures as part of the Company’s Pivotal Human Clinical Trial. The clinical trial is expected to support the future submission to ...

Accelerated Launch Readiness Plans Position Company for Commercialization during Q4 2025The Company’s Initial Addressable Market Includes ...

Microbot Medical today announced its Liberty endovascular surgical robot earned 510 (k) clearance from the U.S. Food and Drug ...

The FDA’s clearance of LIBERTY follows the completion of Microbot’s pivotal trial in April 2025, achieving a 100% success ...